Hepatitis C virus infection has been associated with a variety of extr
ahepatic disorders. We report four patients with membranous glomerulon
ephritis and hepatitis C virus infection. In contrast to patients prev
iously reported with HCV infection and membranoproliferative glomerulo
nephritis, these patients have normal or minimally reduced complement
levels and no evidence of rheumatoid factor or cryoglobulinemia. A liv
er biopsy in one patient was consistent with chronic active hepatitis
although liver enzymes were only minimally elevated and coagulation st
udies normal. Three patients were treated with alpha-interferon with s
ome success. Treatment with alpha-interferon may have a beneficial eff
ect in reducing proteinuria and improving liver function and may be re
lated to the ability of interferon to suppress viremia. Future studies
need to focus on clarifying the role of the virus in causing glomerul
ar disease and improving dosing strategies for alpha-interferon. Rando
mized, controlled studies need to be performed to determine whether th
e beneficial effect of alpha interferon is significant, and if so, if
it is superior to conventional therapies.